Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Devices & Dosimetry

New insight in the treatment of refractory melasma: Laser Q-switched Nd: YAG non-ablative fractionated followed by intense pulsed light

The purpose of our study was to verify the results of the association of Q-switched Nd: YAG non-ablative fractionated with intense pulsed light, in order to treat patients with refractory melasma.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors studied whether combining Q-switched Nd:YAG non-ablative fractionated laser with intense pulsed light could treat refractory melasma. They report that this combination seems to be the best option for hyperpigmentation from melasma, with few side effects. The abstract gives no patient count or outcome data to support these conclusions.

Who or what was studied
Patients with refractory melasma
Limits stated in the abstract
The abstract provides no sample size, outcome measures or control group, so the reported conclusions cannot be checked.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.

Record from PubMed, a service of the National Library of Medicine.

How to read a trial: what to check before relying on this kind of research.

Terms in this paper: Laser. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies

Devices & Dosimetry

Lasers for Melasma

Maintenance treatment is crucial to prevent recurrence. Despite advancements, laser treatments must be approached cautiously due to risks like postinflammatory hyperpigmentation, especially in darker skin types.

Review · May 13, 2026 · Campos V et al.